Ronald Sparks M.'s Insider Trades & SAST Disclosures
Ronald Sparks M.'s most recent trade in Lucid Diagnostics Inc was a trade of 112,800 Common stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ronald Sparks M..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 112,800 | 197,460 | - | 0 | Common stock | |
| Lucid Diagnostics Inc | Ronald Sparks M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
| PAVmed Inc | M. Sparks Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 65,000 | 65,000 (0%) | 0% | - | Common stock | |
| Lucid Diagnostics Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 175,000 | 175,000 | - | - | Employee stock option (right to buy) | |
| PAVmed Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 450,000 | 450,000 | - | - | Employee stock option (right to buy) | |
| PAVmed Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 80,000 | 80,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 59,000 | 59,000 | - | - | Employee stock option (right to buy) | |
| Lucid Diagnostics Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 84,660 | 84,660 | - | 0 | Common stock | |
| PAVmed Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| PAVmed Inc | Ronald M. Sparks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges